Patent ID: 11951311
Assignee: AVENT, INC.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 9:
10. The system of claim 1, the transmucosal electrical stimulation delivered to the treatment site has at least one of:
a pulsed waveform with an envelope ≤1000 ms, an envelope delivery frequency ≤100 Hz, and for durations ≤30 minutes,
a frequency selected from the group consisting of 100 kHz, 200 kHz, 300 kHz, 400 kHz, 500 kHz, 600 kHz, 700 kHz, 800 kHz, 900 kHz and 1 MHz,
an amplitude ranging from 10 mA to 5,000 mA,
an amplitude ranging from 10 V to 1,000 V,
a power ranging from 1 W to 1,250 W,
a generated or induced electrical field strength at the target site and/or the electrode ranging from 20 V/m to 1,000,000 V/m,
a waveform shape component including at least one of a sinusoidal waveform, a square waveform, a triangular waveform, an impulse waveform, a shape modulated waveform, a frequency modulated waveform, or an amplitude modulated waveform that provides a continuous delivery of electrical stimulation at the treatment site and a combination thereof,
a duty cycle ranging from 0.1% to 99%,
an inter-pulse width ranging from 1 ms to 999 ms, or
a duration up to 30 minutes.